Medium Volume Modulates C2C12 Myoblasts Differentiation Efficiency and Expression of Myod1 and Myog
Abstract
Background: Differentiation of C2C12 myoblasts into multinucleated myofibers is a well-established model for studying skeletal muscle biology. While numerous factors influencing myogenesis have been thoroughly investigated, the effects of medium volume during differentiation of myoblasts have not been extensively explored, and most studies do not report the specific medium volumes used during differentiation. In this study, we investigated how medium volume affects myogenic differentiation, metabolic activity, and gene expression in C2C12 cultures.
Materials and methods: The impact of different medium volumes (100, 250, and 400 µL/cm²) on C2C12 differentiation was evaluated over a five-day period, with medium replacement every two days. Morphological assessments and metabolic activity assays were performed at the end of differentiation. Gene expression analyses for Myod1, Myog, Myf6, Myh1 and Myh7 were conducted through RT-qPCR on initial cultures and on the final day of differentiation for comparison.
Results: The expression levels of the early myogenic regulatory factors Myod1 and Myog were inversely correlated with medium volume, whereas the late differentiation markers Myh1 (type II) and Myh7 (type I) remained unaffected. Cultures differentiated with higher medium volume presented both increased metabolic activity and a higher differentiation index at the end of differentiation period.
Conclusion: Medium volume significantly affects the differentiation of C2C12 myoblasts. Higher medium volumes increased myofiber thickness, differentiation index, and metabolic activity, and reduced the expression of the early myogenic markers Myod1 and Myog. These findings highlight medium volume as an important experimental parameter that should be reported alongside medium composition to improve reproducibility and physiological relevance of in vitro skeletal muscle differentiation studies.
Keywords: C2C12 differentiation, myogenesis, myogenic regulatory factors, skeletal muscle in vitro model
Full Text:
PDFReferences
Abdelmoez AM, Sardón Puig L, Smith JA, Gabriel BM, Savikj M, Dollet L, Chibalin AV, Krook A, Zierath JR, Pillon NJ. Comparative profiling of skeletal muscle models reveals heterogeneity of transcriptome and metabolism. Am J Physiol Cell Physiol. 2020; 318(3)C615-26, CrossRef.
Aryana IG, Hapsari AA, Kuswardhani RA. Myokine regulation as marker of sarcopenia in elderly. Mol Cell Biomed Sci. 2018; 2(2): 38-47, CrossRef.
Li L, Huang C, Pang J, Huang Y, Chen X, Chen G. Advances in research on cell models for skeletal muscle atrophy. Biomed Pharmacother. 2023; 167: 115517, CrossRef.
Budaya TN, Daryanto B, Seputra KP, Fabrianta DM, Ekaputra AA, Dewi RR, Anita KW, Dhani FK, Rofifa AF. SARM Rad140 increases osteoblasts, muscle fiber size, myonuclei, and reduces osteoclasts in orchidectomized wistar rats. Mol Cell Biomed Sci. 2025; 9(1): 30-8, CrossRef.
Aryana IG, Winangun IM. Decreased follistatin levels as a risk of acute sarcopenia marker in elderly. Mol Cell Biomed Sci. 2023; 7(3): 147-54, CrossRef.
Lesmana R, Setiawan S, Efza F, Pratiwi YS, Iqbal GM, Goenawan H, Sylviana N, Supratman U. Ethionamide Alters Thyroid Receptor Gene Expression in Rats' Muscle. Indones Biomed J. 2020; 12(3): 220-6, CrossRef.
Uchimura T, Otomo J, Sato M, Sakurai H. A human iPS cell myogenic differentiation system permitting high-throughput drug screening. Stem Cell Res. 2017; 25: 98-106, CrossRef.
Yaffe D, Saxel O. A myogenic cell line with altered serum requirements for differentiation. Differentiation. 1977; 7(1-3): 159-66, CrossRef.
Wong CY, Al-Salami H, Dass CR. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol. 2020; 72(12): 1667-93, CrossRef.
Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, Falcieri E. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur J Histochem. 2004; 48(3): 223-34, article.
Ferri P, Barbieri E, Burattini S, Guescini M, D'Emilio A, Biagiotti L, Del Grande P, De Luca A, Stocchi V, Falcieri E. Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts. J Cell Biochem. 2009; 108(6): 1302-17, CrossRef.
Veliça P, Bunce CM. A quick, simple and unbiased method to quantify C2C12 myogenic differentiation. Muscle & Nerve. 2011; 44(3): 366-70, CrossRef.
Storaasli Z, Zhao Y, Touma M. Gene Expression during C2C12 Differentiation. Vanderbilt Undergraduate Res J. 2024; 14(1) , CrossRef.
Cooper ST, Maxwell AL, Kizana E, Ghoddusi M, Hardeman EC, Alexander IE, Allen DG, North KN. C2C12 co-culture on a fibroblast substratum enables sustained survival of contractile, highly differentiated myotubes with peripheral nuclei and adult fast myosin expression. Cell Mot Cytos. 2004; 58(3): 200-11, CrossRef.
Lawson MA, Purslow PP. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs. 2000; 167(2-3): 130-7, CrossRef.
Jang M, Scheffold J, Røst LM, Cheon H, Bruheim P. Serum-free cultures of C2C12 cells show different muscle phenotypes which can be estimated by metabolic profiling. Sci Rep. 2022; 12(1): 827, CrossRef.
Siengdee P, Trakooljul N, Murani E, Schwerin M, Wimmers K, Ponsuksili S. MicroRNAs regulate cellular ATP levels by targeting mitochondrial energy metabolism genes during C2C12 myoblast differentiation. PloS One. 2015; 10(5): e0127850, CrossRef.
Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9(7): 671-5, CrossRef.
Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima YI. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci. 1998; 111(6): 769-79, CrossRef.
Masilamani TJ, Loiselle JJ, Sutherland LC. Assessment of reference genes for real-time quantitative PCR gene expression normalization during C2C12 and H9c2 skeletal muscle differentiation. Mol Biotech. 2014; 56(4): 329-39, CrossRef.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9): e45-9, CrossRef.
Hernández-Hernández JM, García-González EG, Brun CE, Rudnicki MA. The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. Semin Cell Dev Biol. 2017; 72: 10-8, CrossRef.
Meiliana A, Dewi NM, Wijaya A. Molecular regulation and rejuvenation of muscle stem (satellite) cell aging. Indones Biomed J. 2015; 7(2): 73-86, CrossRef.
Hinterberger TJ, Sassoon DA, Rhodes SJ, Konieczny SF. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev Biol. 1991; 147(1): 144-56, CrossRef.
Meiliana A, Dewi NM, Wijaya A. Sarcopenia as a risk of modern obesity treatments: a review of molecular mechanisms and prevention strategies. Indones Biomed J. 2025; 17(6): 511-26, CrossRef.
Bataille S, McKay N, Koppe L, Beau A, Benoit B, Bartoli M, Da Silva N, Poitevin S, Aniort J, Chermiti R, Burtey S. Indoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation. Nephrol Dial Transplant. 2024; 39(1): 103-13, CrossRef.
Stuart CA, Stone WL, Howell ME, Brannon MF, Hall HK, Gibson AL, Stone MH. Myosin content of individual human muscle fibers isolated by laser capture microdissection. Am J Physiol Cell Physiol. 2016; 310(5): C381-9, CrossRef.
Yasuda T, Ishihara T, Ichimura A, Ishihara N. Mitochondrial dynamics define muscle fiber type by modulating cellular metabolic pathways. Cell Rep. 2023; 42(5): 112434. , CrossRef.
Wang JH, Wang QJ, Wang C, Reinholt B, Grant AL, Gerrard DE, Kuang S. Heterogeneous activation of a slow myosin gene in proliferating myoblasts and differentiated single myofibers. Dev Biol. 2015; 402(1): 72-80, CrossRef.
Yoshimura Y, Kikuiri T, Hasegawa T, Matsuno M, Minamikawa H, Deyama Y, Suzuki K. How much medium do you use for cell culture? Medium volume influences mineralization and osteoclastogenesis in vitro. Mol Med Rep. 2017; 16(1): 429-34, CrossRef.
Hass DT, Zhang Q, Autterson GA, Bryan RA, Hurley JB, Miller JM. Medium depth influences O2 availability and metabolism in human RPE cultures. Invest Ophthalmol Vis Sci. 2023; 64(14): 4, CrossRef.
Gstraunthaler G, Seppi T, Pfaller W. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures: are renal cells in tissue culture hypoxic?. Cell Physiol Biochem. 1999; 9(3): 150-72, CrossRef.
Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005; 11: 127-52, CrossRef.
Mastroyiannopoulos NP, Nicolaou P, Anayasa M, Uney JB, Phylactou LA. Down-regulation of myogenin can reverse terminal muscle cell differentiation. PloS One. 2012; 7(1): e29896, CrossRef.
Andrés V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996; 132(4): 657-66, CrossRef.
Zammit PS. Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin Cell Dev Biol. 2017; 72: 19-32, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v10i3.813
Copyright (c) 2026 Molecular and Cellular Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
1.jpg){kind=logo}
